Navigation Links
Impax's Second Quarter 2014 Revenues Increased 45% to $188.1 Million
Date:8/6/2014

such forward-looking statements. Such risks and uncertainties include, but are not limited to: fluctuations in revenues and operating income; the Company's ability to promptly correct the issues raised in the warning letter and Form 483 observations received from the FDA; the Company's ability to successfully develop and commercialize pharmaceutical products in a timely manner; reductions or loss of business with any significant customer; the impact of consolidation of the Company's customer base; the impact of competition; the substantial portion of our total revenues derived from sales of a limited number of products; the Company's ability to sustain profitability and positive cash flows; any delays or unanticipated expenses in connection with the operation of the Company's manufacturing facilities; the effect of foreign economic, political, legal, and other risks on the Company's operations abroad; the uncertainty of patent litigation and other legal proceedings; the increased government scrutiny on the Company's agreements with brand pharmaceutical companies; product development risks and the difficulty of predicting FDA filings and approvals; consumer acceptance and demand for new pharmaceutical products; the impact of market perceptions of the Company and the safety and quality of the Company's products; the Company's determinations to discontinue the manufacture and distribution of certain products; the Company's ability to achieve returns on its investments in research and development activities; the Company's inexperience in conducting clinical trials and submitting new drug applications; the Company's ability to successfully conduct clinical trials; the Company's reliance on third parties to conduct clinical trials and testing; the Company's lack of a license partner for commercialization of IPX066 outside of the United States; impact of illegal distribution and sale by third parties of counterfeits or stolen products; the availability of raw materials and
'/>"/>
SOURCE Impax Laboratories, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related medicine technology :

1. Hanger Reschedules Second Quarter 2014 Earnings Release and Conference Call
2. China Biologic Reports Financial Results for the Second Quarter of 2014
3. Jazz Pharmaceuticals Announces Second Quarter 2014 Financial Results And Updated Guidance
4. Cumberland Pharmaceuticals Reports Second Quarter 2014 Financial Results
5. VirtualScopics, Inc. Schedules Second Quarter 2014 Financial Results Press Release, Conference Call And Webcast
6. Concord Medical to Report Second Quarter 2014 Financial Results on August 13, 2014
7. CPHI to Hold Second Quarter 2014 Earnings Conference Call on Friday August 15, 2014 at 8:30 a.m. ET
8. Discovery Labs Reports Second Quarter 2014 Financial Results
9. AMRI Announces Second Quarter 2014 Results
10. CVS Caremark Reports Record Second Quarter Results
11. Lexicon To Report Second Quarter 2014 Financial Results On August 7, 2014
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... and BOSTON , September 16, 2014 ... Scientific Officer, Fiona Marshall , will give a presentation ... protein-coupled receptors using StaR ®   technology ... in Drug Discovery and Development " virtual symposium run by ... Society. The virtual symposium is on Wednesday, 24 September 2014; ...
(Date:9/15/2014)... , Sept. 16, 2014 The French ... (HNF) announced today an agreement to collaborate on programs ... support the development of a stronger CMT patient and ... support to several HNF,s initiatives including: , ... the HNF website featuring  HNF newsletters, materials and latest ...
(Date:9/15/2014)... Sept. 16, 2014  Bayer HealthCare and Orion ... Finland , have begun to enroll ... an investigational oral androgen receptor inhibitor in clinical ... men with castration-resistant prostate cancer who have rising ... metastases. The trial is designed to determine the ...
Breaking Medicine Technology:Heptares to Present on Structure-Based Drug Design Using G Protein-Coupled Receptors at Inaugural Chemistry & Engineering News Virtual Symposium 2Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 2Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 3Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 4Bayer and Orion Initiate Phase III Trial of ODM-201 in Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer 2Bayer and Orion Initiate Phase III Trial of ODM-201 in Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer 3
... Nov. 5, 2010 EnVivo Pharmaceuticals today announced it ... agonist, possesses a novel mechanism not previously seen in ... Acetylcholine (ACh) to enhance cognition. By acting ... makes it possible for smaller amounts of naturally occurring ...
... Nov. 5, 2010 Cadence Pharmaceuticals, Inc. (Nasdaq: ... developing and commercializing proprietary product candidates principally for use ... the three and nine months ended September 30, 2010. ... U.S. Food and Drug Administration (FDA) approved OFIRMEV™ (acetaminophen) ...
Cached Medicine Technology:EnVivo Pharmaceuticals Research Shows EVP-6124 Acts as Acetylcholine Co-Agonist 2EnVivo Pharmaceuticals Research Shows EVP-6124 Acts as Acetylcholine Co-Agonist 3Cadence Pharmaceuticals Reports Third Quarter 2010 Financial Results 2Cadence Pharmaceuticals Reports Third Quarter 2010 Financial Results 3Cadence Pharmaceuticals Reports Third Quarter 2010 Financial Results 4Cadence Pharmaceuticals Reports Third Quarter 2010 Financial Results 5Cadence Pharmaceuticals Reports Third Quarter 2010 Financial Results 6
(Date:9/16/2014)... QuickMedical, a national leader in the ... veteran-owned small business has officially launched three new ... Nipro Medical, and CP Medical Sutures. , ... best, most affordable medical equipment and supplies. To ... effort to reach new medical facilities, QuickMedical has ...
(Date:9/16/2014)... Richmond, VA (PRWEB) September 16, 2014 ... Museum of Virginia this fall. Reflecting on what it ... Ethics: Expanding Community Vision investigates unique and thought-provoking topics. ... people to be inspired to look at their world ... provoking and set the stage for truly enlightening dialogue,” ...
(Date:9/16/2014)... Today, the Diamond in the Raw Foundation ... held, Sunday, October 19, 2014 at the Skirball Cultural ... show honors the dare-devil stuntwomen of film and television ... Over 12 categories will be recognized in the two-hour ... , Special honors will be given to legendary stuntwomen ...
(Date:9/16/2014)... N.C. (PRWEB) September 16, 2014 Triad ... President & CEO of Intersil and former President of ... of directors. , “David has extraordinary technology and business ... Triad’s board of directors,” said Lynn Hayden, Triad CEO ... years of analog and mixed signal semiconductor experience to ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 A peep-toe ... back, bootie, or any other dress shoe) in which ... the toes to show. Peep-toe shoes were popular beginning ... shoes had a brief resurgence in the 1970s/80s, before ... they have enjoyed some popularity again, with variations such ...
Breaking Medicine News(10 mins):Health News:Expanding Community Vision at the Science Museum of Virginia 2Health News:Hollywood's Action Icon Awards to Honor Legendary Stuntwomen In A Star-Studded Gala and Awards Ceremony 2Health News:David Bell Joins Triad Semiconductor's Board of Directors 2Health News:Nice Peep Toes Are For Sale At Fecbek.com 2
... THURSDAY, Dec. 15 (HealthDay News) -- Lack of time is ... suggests that several short intensive workouts a week may help ... regimens. The small, new study found that 30 ... time of 75 minutes a week with warm-up and cool-down ...
... -- Nearly 20 million Americans who see a dentist at ... general health care provider, which suggests that dentists could screen ... pressure, diabetes and heart disease, a new study says. ... adults who took part in the 2008 U.S. National Health ...
... , THURSDAY, Dec. 15 (HealthDay News) - To catch cervical ... human papillomavirus (HPV) test is the best option for women ... with the more traditional Pap smear resulted in earlier detection ... developing, said study author Dr. Chris Meijer, a professor of ...
... researchers at the University of Alberta have discovered a new ... those living with the disease, by using a powerful, triple ... brain tissue. The researchers discovered that iron levels in ... brain that are responsible for relaying messages. High iron levels ...
... coffee maker, and the simple quest becomes, well, an ordeal. After ... you finally make a purchase, only to wonder: "Was this the ... Reality check: Is this you? If so, new research ... to make a decision that you,ll be happy with. Joyce ...
... (HealthDay News) -- Low levels of iron in the blood ... that form in a vein, according to the results of ... vessel disease. The findings suggest that treating iron deficiency ... (DVT), according to the researchers at Imperial College London in ...
Cached Medicine News:Health News:Brief, Intense Exercise Lowers Blood Sugar, Small Study Finds 2Health News:Brief, Intense Exercise Lowers Blood Sugar, Small Study Finds 3Health News:Dentists Could Fill Gap in Health Care, Study Says 2Health News:HPV Test Spots Cervical Cancer Earlier Than Pap Smear: Study 2Health News:HPV Test Spots Cervical Cancer Earlier Than Pap Smear: Study 3Health News:Using powerful MRI to track iron levels in brain could be new way to monitor progression of MS 2Health News:Psychology researcher finds that second-guessing one's decisions leads to unhappiness 2Health News:Psychology researcher finds that second-guessing one's decisions leads to unhappiness 3Health News:Low Iron Levels May Increase Blood Clot Risk 2
The ELISA test is used for detection and semi quantitation of igG antibodies to proteinase 3(PR3) in human sera, as an aid to the diagnosis is of Wegener's granulomatosis....
... Acolytes core technology relates to the ultrasensitive ... found in all living cells. ATP ... using bioluminescence. By coupling AK ... via extraction using antibody-coated beads, Acolyte can ...
... DYONICS POWERMAX Shaver Handpiece has 25% more ... standard Smith & Nephew handpiece providing optimal ... handling and reduced hand fatigue. ,The forward/reverse ... suction lever are all co-located to allow ...
... tailored to individual needs. The pump can ... Indeed a Shaver unit only is featured ... and handpiece.,The REVOLUTION shaver system features a ... progressive motor (up to 4.000 rpm). When ...
Medicine Products: